Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
about
Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.Major depressive disorder and bone mass in adolescents and young adults.Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.Update in serotonin and bone.Effects of escitalopram on markers of bone turnover: a randomized clinical trialRelationship between use of antidepressants and risk of fractures: a meta-analysis.Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?Association between depressive symptoms and bone stiffness index in young adults: the Kangwha study.Serotonin and the bone assessmentA Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.Characterization of trabecular bone plate-rod microarchitecture using multirow detector CT and the tensor scale: Algorithms, validation, and applications to pilot human studies.Care of the human immunodeficiency virus-infected menopausal woman.SSRIs: bad to the bone?Brains, bones, and aging: psychotropic medications and bone health among older adults.Use of antidepressant medications and risk of fracture in older womenAntidepressants and fracture risk in older adults: a comparative safety analysis.The complex interplay of depression and falls in older adults: a clinical review.The serotonin and the bone assessmentEffects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan.Rates of bone loss among women initiating antidepressant medication use in midlifeSerotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.Osteoporosis and polypharmacy.Role of inflammation in HIV-1 disease progression and prognosis.Adverse skeletal effects of drugs - beyond Glucocorticoids.Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors.Management of psychiatric and neurological comorbidities in epilepsy.Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study.Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs.The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults.
P2860
Q33900986-A72970A0-0DCA-4E20-A90A-A1132143BAEAQ33922382-20E567C1-6CEC-4678-AA5C-BB83392F6CB7Q33955124-D0262BBE-9C13-49F9-9AF4-B96C48FCBE33Q34113148-739DF85D-D8B4-4FFC-A8CE-FEFFFE16236BQ34130880-4E9E9735-6A81-41CD-8C3A-A594D9824D41Q34277620-F05A23BD-D875-4127-9A15-948DD08387A9Q34432269-6F333803-EE5E-4595-893C-FDF411EE2964Q34501008-ED332191-2CE3-418E-A1FA-E3778BB70E20Q34536565-02048B38-509E-482B-89B9-DC32DD0CAE83Q34874904-E5076265-4ABB-4F90-835C-4009E4C56D1EQ35339741-EEBEFE08-ADF8-453C-A2BF-FE01ADBDC73EQ35755034-88524A19-F7EB-4705-9AFF-A1395E6C555CQ35983087-4EB0E12A-0D4D-4F74-AC85-484FDD7546F5Q36128333-A0D4C722-7D35-4296-B85C-C2211B39BE76Q36235126-FCFBC762-BE64-481C-9C1A-C4346367824AQ36427958-468F7663-7C8D-4A04-AD4C-14FF589280F9Q36526151-153A7021-66DE-4599-8C91-00C14C034522Q36817545-D460C6A9-67CF-41A0-A710-EA200E1779BCQ36936093-B147C006-AAC5-4EDE-B57A-9EF275A3A810Q37050668-8B94A25C-8C8D-4B5C-9CE9-5412C63FB611Q37256907-D4A852DC-3FA3-4680-BA4A-75C7512D1890Q37275988-79221A99-4F26-4914-9036-B148719F90BFQ37317822-5FFA2A45-3B62-4330-9297-974F8F4ACFD3Q38027084-FC0A4ADB-5DCC-4B40-9F87-2A523EC06C29Q38183454-0CF06580-8CEA-400F-8DA7-FD4B6D4082F5Q38231316-363723F0-B629-4CC0-B8AD-D44D1CE4D865Q38612952-91A09255-A74F-427C-AABD-C5623FD51B3EQ38702125-99A593B2-2240-494B-9138-15C3BD1E5674Q39038647-6F68D940-D12F-4937-8F8A-E13410D96F5BQ39657169-B980BA06-8356-4471-AFC3-C6C82B974943Q40781394-177AA619-DC82-44D2-8A5E-4FE1927B55FEQ47368888-954BCAD6-6D18-4E0A-AA08-6A829ACC51AAQ47665702-D9E281EF-26B9-44DB-94DC-BBE14BE10B8A
P2860
Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Effects of selective serotonin ...... ng, prevention and management?
@ast
Effects of selective serotonin ...... ng, prevention and management?
@en
type
label
Effects of selective serotonin ...... ng, prevention and management?
@ast
Effects of selective serotonin ...... ng, prevention and management?
@en
prefLabel
Effects of selective serotonin ...... ng, prevention and management?
@ast
Effects of selective serotonin ...... ng, prevention and management?
@en
P2093
P2860
P1433
P1476
Effects of selective serotonin ...... ng, prevention and management?
@en
P2093
Elizabeth M Haney
M Michael Bliziotes
Stuart J Warden
P2860
P356
10.1016/J.BONE.2009.07.083
P577
2009-08-05T00:00:00Z